Deployment of Rotavirus Vaccine in Western Kenya Coincides with a Reduction in All-Cause Child Mortality: A Retrospective Cohort Study

Rotavirus is an important cause of fatal pediatric diarrhea worldwide. Many national immunization programs began adding rotavirus vaccine following a 2009 World Health Organization recommendation. Kenya added rotavirus vaccine to their immunization program at the end of 2014. From a cohort of 38,463 children in the Kisumu health and demographic surveillance site in western Kenya, we assessed how the implementation of the rotavirus vaccine affected mortality in children under 3 years of age. Following its introduction in late 2014, the span of rotavirus vaccine coverage for children increased to 75% by 2017. Receiving the rotavirus vaccine was associated with a 44% reduction in all-cause child mortality (95% confidence interval = 28–68%, p < 0.0001), but not diarrhea-specific mortality (p = 0.401). All-cause child mortality declined 2% per month following the implementation of the rotavirus vaccine (p = 0.002) among both vaccinated and unvaccinated children, but diarrhea-specific mortality was not associated with the implementation of the rotavirus vaccine independent of individual vaccine status (p = 0.125). The incidence of acute diarrhea decreased over the study period, and the introduction of the rotavirus vaccine was not associated with population-wide trends (p = 0.452). The receipt of the rotavirus vaccine was associated with a 34% reduction in the incidence of diarrhea (95% confidence interval = 24–43% reduction). These results suggest that rotavirus vaccine may have had an impact on all-cause child mortality. The analyses of diarrhea-specific mortality were limited by relatively few deaths (n = 57), as others have found a strong reduction in diarrhea-specific mortality. Selection bias may have played a part in these results—children receiving rotavirus vaccine were more likely to be fully immunized than children not receiving the rotavirus vaccine.

[1]  D. Larsen,et al.  Examining Wealth Trends in Kombewa, Kenya , 2021, Social Indicators Research.

[2]  A. Costello,et al.  Population impact and effectiveness of sequential 13-valent pneumococcal conjugate and monovalent rotavirus vaccine introduction on infant mortality: prospective birth cohort studies from Malawi , 2020, BMJ Global Health.

[3]  P. Szilagyi,et al.  Evidence for Household Transmission of Rotavirus in the United States, 2011-2016. , 2020, Journal of the Pediatric Infectious Diseases Society.

[4]  J. Tate,et al.  Effectiveness of Monovalent Rotavirus Vaccine Against Hospitalization With Acute Rotavirus Gastroenteritis in Kenyan Children , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  K. Marsh,et al.  Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study , 2019, The Lancet.

[6]  J. Tate,et al.  Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010–2013 , 2019, BMC Infectious Diseases.

[7]  J. Platts-Mills,et al.  Rotavirus vaccine impact in Africa: greater than the sum of its parts? , 2018, The Lancet. Global health.

[8]  C. Murray,et al.  Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years , 2018, JAMA pediatrics.

[9]  A. Costello,et al.  Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study , 2018, The Lancet. Global health.

[10]  J. Tate,et al.  A decade of experience with rotavirus vaccination in the United States – vaccine uptake, effectiveness, and impact , 2018, Expert review of vaccines.

[11]  S. Komoto,et al.  Impact of rotavirus vaccination on rotavirus hospitalisation rates among a resource‐limited rural population in Mbita, Western Kenya , 2018, Tropical medicine & international health : TM & IH.

[12]  W. Otieno,et al.  Cause-specific mortality in the Kombewa health and demographic surveillance systems site, rural Western Kenya from 2011–2015 , 2018, Global health action.

[13]  Stephen S. Lim,et al.  Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Infectious diseases.

[14]  E. Burnett,et al.  Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality From Diarrhea , 2017, The Journal of infectious diseases.

[15]  L. Lamberti,et al.  A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years , 2016, The Pediatric infectious disease journal.

[16]  L. Cuevas,et al.  Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis , 2016, Infectious Diseases of Poverty.

[17]  J. Tate,et al.  Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Paul A. Gastañaduy,et al.  Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Tate,et al.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  A. Costello,et al.  Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  N. Alvis-Guzmán,et al.  Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries. , 2015, Vaccine.

[22]  Rachel Jenkins,et al.  Prevalence of malaria parasites in adults and its determinants in malaria endemic area of Kisumu County, Kenya , 2015, Malaria Journal.

[23]  Rachel Jenkins,et al.  Prevalence of malaria parasites in adults and its determinants in malaria endemic area of Kisumu County, Kenya , 2015, Malaria Journal.

[24]  B. Böttiger,et al.  A case-control study of risk factors for rotavirus infections in adults, Denmark, 2005–2009 , 2015, Epidemiology and Infection.

[25]  C. Atchison,et al.  Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. , 2015, Vaccine.

[26]  S. Madhi,et al.  Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study. , 2014, The Lancet. Infectious diseases.

[27]  W. Otieno,et al.  Health & demographic surveillance system profile: The Kombewa health and demographic surveillance system (Kombewa HDSS). , 2014, International journal of epidemiology.

[28]  U. Parashar,et al.  Correction: Household Transmission of Rotavirus in a Community with Rotavirus Vaccination in Quininde, Ecuador , 2013, PLoS ONE.

[29]  U. Parashar,et al.  Household Transmission of Rotavirus in a Community with Rotavirus Vaccination in Quininde, Ecuador , 2013, PloS one.

[30]  A. Ciapponi,et al.  Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries. , 2013, Vaccine.

[31]  B. Hull,et al.  Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience. , 2013, Vaccine.

[32]  J. Kombich,et al.  Immunization coverage and its determinants among children aged 12 - 23 months in a peri-urban area of Kenya , 2013, The Pan African medical journal.

[33]  A. Ezeh,et al.  Health and demographic surveillance systems: a step towards full civil registration and vital statistics system in sub-Sahara Africa? , 2012, BMC Public Health.

[34]  Samuel J. Clark,et al.  Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool , 2012, Global health action.

[35]  J. Tate,et al.  Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  M. Loeb,et al.  Vaccine herd effect , 2011, Scandinavian journal of infectious diseases.

[37]  D. Nokes,et al.  Rotavirus genetic diversity, disease association, and temporal change in hospitalized rural Kenyan children. , 2010, The Journal of infectious diseases.

[38]  M. Levine,et al.  Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial , 2010, The Lancet.

[39]  W. Straus,et al.  Burden of Childhood Rotavirus Disease on Health Systems in the United States: Results From Active Surveillance Before Rotavirus Vaccine Introduction , 2010, The Pediatric Infectious Disease Journal.

[40]  Manish M Patel,et al.  Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. , 2010, The New England journal of medicine.

[41]  Manish M Patel,et al.  Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. , 2009, The Journal of infectious diseases.

[42]  J. Tate,et al.  Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya. , 2009, The Journal of infectious diseases.

[43]  Peter Byass,et al.  Who Needs Cause-of-Death Data? , 2007, PLoS medicine.

[44]  P. Dennehy Rotavirus vaccines: an update , 2005, Current opinion in pediatrics.

[45]  G. Malhi,et al.  Recommendations , 2009, Acta Neuropsychiatrica.

[46]  M. Anker,et al.  The effect of misclassification error on reported cause-specific mortality fractions from verbal autopsy. , 1997, International journal of epidemiology.

[47]  Rotavirus vaccines WHO position paper: January 2013 - Recommendations. , 2013, Vaccine.